Family Medicine · Chicago, IL
NPI
1629045778
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6201 W Touhy Ave
Chicago, IL, 60646
Phone (847) 673-5166
Groups this clinician bills Medicare through
Medicare paid, 2024
$549K
15,559 services
Medicare patients, 2024
776
Average age 73
Drug cost, 2024
$3.2M
30,566 prescriptions
Company payments, 2025
$2,690
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdulmassih Abdulmassih was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,176 times for 48 patients. In total Abdulmassih Abdulmassih billed 15,559 services in 139 codes, and Medicare paid $549K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-04.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,176 | 48 | $0.10 | $421 |
| 99214 Office E&M - Established | Office | 2,015 | 612 | $90.55 | $182K |
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 960 | 11 | $13.68 | $13K |
| 36415 Venipuncture Blood Collection | Office | 882 | 504 | $8.65 | $7,629 |
| 99213 Office E&M - Established | Office | 747 | 320 | $63.66 | $48K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 423 | 423 | $19.19 | $8,116 |
| 99233 Hospital E&M - Subsequent | Facility | 422 | 64 | $97.33 | $41K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 402 | 402 | $19.19 | $7,714 |
| 96372 Injection Administration | Office | 400 | 125 | $10.96 | $4,385 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 392 | 392 | $133.26 | $52K |
| 81003 Clinical Chemistry | Office | 316 | 186 | $2.20 | $695 |
| 97110 PT Treatment | Office | 311 | 46 | $17.69 | $5,501 |
| 97140 PT Treatment | Office | 276 | 41 | $16.25 | $4,484 |
| 80061 Clinical Chemistry | Office | 274 | 157 | $13.12 | $3,595 |
| 97112 PT Treatment | Office | 262 | 41 | $21.86 | $5,727 |
By year: 2022 $577K for 12,022 services; 2023 $415K for 8,193 services; 2024 $549K for 15,559 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 882 | 504 | $8.65 | $7,629 |
| 81003 Clinical Chemistry | 316 | 186 | $2.20 | $695 |
| 80061 Clinical Chemistry | 274 | 157 | $13.12 | $3,595 |
| 82962 Clinical Chemistry | 259 | 152 | $3.21 | $831 |
| 83036 Blood Count | 257 | 146 | $9.52 | $2,447 |
| 82044 Clinical Chemistry | 251 | 143 | $6.11 | $1,534 |
| 0241U Infectious Agent Detection by DNA/RNA | 75 | 67 | $136.78 | $10K |
| 87636 Infectious Agent Detection by DNA/RNA | 25 | 24 | $139.78 | $3,495 |
Medicare prescription drug claims, 2024
In 2024, the drug Abdulmassih Abdulmassih prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,197 prescriptions and refills. In total Abdulmassih Abdulmassih wrote 30,566 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,197 | 2,073 | 281 | $8,584 |
| Rosuvastatin Calcium Generic | 822 | 1,426 | 191 | $9,313 |
| Metformin Hcl Generic | 713 | 1,320 | 173 | $3,359 |
| Amlodipine Besylate Generic | 680 | 1,214 | 165 | $3,402 |
| Diclofenac Sodium Generic | 602 | 666 | 126 | $139K |
| Fluticasone Propionate Generic | 525 | 680 | 173 | $5,191 |
| Omeprazole Generic | 513 | 794 | 137 | $4,014 |
| Levothyroxine Sodium Generic | 500 | 901 | 116 | $4,139 |
| Metoprolol Succinate Generic | 441 | 780 | 109 | $5,638 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 426 | 521 | 86 | $15K |
| Metoprolol Tartrate Generic | 421 | 750 | 108 | $2,294 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 415 | 415 | 83 | $9,348 |
| Eliquis Apixaban | 403 | 456 | 53 | $193K |
| Gabapentin Generic | 403 | 504 | 86 | $4,691 |
| Furosemide Generic | 385 | 565 | 98 | $1,362 |
Brand drugs: 4,928 claims; generic drugs: 24,842 claims; opioid claims: 782.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdulmassih Abdulmassih $2,690 ($2,690 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novo Nordisk Inc with $387.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $387 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $282 |
| Pfizer Inc. PFE | 14 | $197 |
| Abbvie Inc. ABBV | 13 | $190 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 9 | $163 |
| Lilly USA, LLC LLY | 8 | $162 |
| Amgen Inc. AMGN | 6 | $114 |
| Exact Sciences Corporation EXAS | 5 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.